Renew™ NCP-5 External Counterpulsation System

Indications for Use Cleared by U.S. Food and Drug Administration

The Renew™ NCP-5 External Counterpulsation System is intended for the treatment of chronic stable angina that is refractory to optimal anti-anginal medical therapy and without options for revascularization. It is intended for use to provide improvement in vasodilation, increase VO2 and increase blood flow. It is intended for use under the oversight of a healthcare professional.

 

NCP-5 ECP Unit Operator and patient